A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers

NCT02928354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma, Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Treatment A - AZD7594
DRUG: Treatment B - AZD7594
DRUG: Treatment C - AZD7594

Sponsor

AstraZeneca